Incyte
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.About INCY
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.
INCY Key Statistics
INCY News
J.P. Morgan analyst Jessica Fye has maintained their neutral stance on INCY stock, giving a Hold rating today. Elevate Your Investing Strategy: Take advantage o...
In a report released today, Judah Frommer from Morgan Stanley maintained a Hold rating on Incyte, with a price target of $79.00. Elevate Your Investing Strategy...
Incyte (INCY) announced the first clinical data evaluating its TGFbetaR2PD-1 bispecific antibody for patients with microsatellite stable, MSS, colorectal cancer...
Analyst ratings
57%
of 28 ratingsMore INCY News
Insiders have been trading these 5 stocks: ((BINI)), ((CRDO)), ((AMBA)), ((CIFR)) and ((INCY)). Here is a breakdown of their recent trades and their value. Elev...
Incyte (INCY) recently shared promising results from early-stage clinical trials of two potential therapies for advanced cancers, including colorectal and pancr...